Author:
Escalante Jenny,Hamza Mase,Nishimura Brent,Melecio Meghan,Davies-Sala Carol,Tuttobene Marisel R.,Subils Tomás,Traglia German M.,Pham Chloe,Sieira Rodrigo,Actis Luis A.,Bonomo Robert A.,Tolmasky Marcelo E.,Ramirez María Soledad
Funder
National Institutes of Health
Cleveland Department of Veterans Affairs
Publisher
Springer Science and Business Media LLC
Reference35 articles.
1. Ren, X. & Palmer, L. D. Acinetobacter metabolism in infection and antimicrobial resistance. Infect. Immun. 91, e00433–e522 (2023).
2. Tacconelli, E. et al. Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 18, 318–327 (2018).
3. Wong, D. et al. Clinical and pathophysiological overview of Acinetobacter infections: A century of challenges. Clin. Microbiol. Rev. 30, 409–447 (2017).
4. Ding, R., Li, X., Zhang, X., Zhang, Z. & Ma, X. The Epidemiology of symptomatic catheter-associated urinary tract infections in the intensive care unit: A 4-year single center retrospective study. Urol. J. 16, 312–317 (2019).
5. Kumar, S. et al. Prospective surveillance of device-associated health care–associated infection in an intensive care unit of a tertiary care hospital in New Delhi, India. Am. J. Infect. Control 46, 202–206 (2018).